SINTX Technologies 

€0
128
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

15MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-6.78
-4.68
-2.58
-0.47
Expected EPS
-0.47166350000000007
Actual EPS
N/A

Financials

-379.77%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
5.47MRevenue
-20.77MNet Income

Analyst Ratings

$9.11Average Price Target
The highest estimate is 9.11.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1110.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. competes in the development, manufacturing, and marketing of orthopedic reconstructive products, a sector where SINTX's silicon nitride technology can be applied.
Stryker
SYK
Mkt Cap126.97B
Stryker Corporation is a direct competitor in the medical technology market, offering products in orthopedics, a key area for SINTX Technologies.
Medtronic
MDT
Mkt Cap111.22B
Medtronic plc operates in the medical device sector, offering products that could compete with SINTX's advanced materials for spinal and orthopedic applications.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson engages in the research and development, manufacture, and sale of a broad range of products in the healthcare field, including orthopedic devices.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation specializes in the development, manufacturing, and marketing of medical devices that could be in direct competition with SINTX's technology in various applications.
Globus Medical
GMED
Mkt Cap11.89B
Globus Medical, Inc. focuses on the design, development, and commercialization of musculoskeletal implants that could compete with SINTX's silicon nitride technology.
Alphatec
ATEC
Mkt Cap1.66B
Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology, competing directly with SINTX's offerings in the spinal market.
K2 Capital Acquisition
KTWO
Mkt Cap0
K2M Group Holdings, Inc. was involved in the design, development, and commercialization of complex spine and minimally invasive spine technologies, competing in the same sector as SINTX, before being acquired by Stryker.

About

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Show more...
CEO
ISIN
US8293927039
WKN
000A40DG1

Listings

0 Comments

Share your thoughts

FAQ

What is SINTX Technologies stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange SINTX Technologies stocks are traded under the ticker 1110.F.
When is the next SINTX Technologies earnings date?
SINTX Technologies is going to release the next earnings report on May 15, 2026.
What were SINTX Technologies earnings last quarter?
1110.F earnings for the last quarter are -0.48 EUR per share, whereas the estimation was -0.48 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is SINTX Technologies revenue for the last year?
SINTX Technologies revenue for the last year amounts to 5.47M EUR.
What is SINTX Technologies net income for the last year?
1110.F net income for the last year is -20.77M EUR.
When did SINTX Technologies complete a stock split?
The last stock split for SINTX Technologies was on May 28, 2024 with a ratio of 1:200.